dr krishna ella

Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the Covid-19 nasal vaccine have been completed and the company will submit its data with Drugs…

HYDERABAD: Bharat Biotech International Limited (BBIL)’s whole-virion inactivated Covid-19 vaccine candidate Covaxinhas proven to be safe, well-tolerated, and highly immunogenic in children aged 2-18 years in a phase II/III study, the…